International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors
RHEUMATOLOGY, vol.56, no.12, pp.2102-2108, 2017 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 56 Issue: 12
- Publication Date: 2017
- Doi Number: 10.1093/rheumatology/kex305
- Journal Name: RHEUMATOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.2102-2108
- Keywords: interleukin-1 inhibitors, anakinra, canakinumab, pregnancy, autoinflammatory disease, CAPS, TRAPS, biologic therapies, familial Mediterranean fever, adult onset stills disease, FAMILIAL MEDITERRANEAN FEVER, AUTOINFLAMMATORY DISEASES, REPRODUCTIVE-SYSTEM, ANAKINRA, EMBRYO
- Istanbul University Affiliated: Yes
Abstract
Objective. To provide outcome data concerning pregnancies exposed to the Interleukin-1 (IL-1) inhibitors prior to conception in both men and women, during pregnancy and breast feeding.